BARCLAYS PLC - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 2 filers reported holding ROYALTY PHARMA PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$35,664
+5.1%
1,314,079
+19.1%
0.02%
+4.8%
Q2 2023$33,928
+117.3%
1,103,665
+154.6%
0.02%
+200.0%
Q1 2023$15,617
-1.8%
433,461
+7.8%
0.01%0.0%
Q4 2022$15,896
-99.8%
402,190
+82.2%
0.01%
-30.0%
Q3 2022$8,868,000
+0.1%
220,693
+4.7%
0.01%
+100.0%
Q2 2022$8,862,000
+22.6%
210,779
+13.6%
0.01%
-16.7%
Q1 2022$7,231,000185,5600.01%
Other shareholders
ROYALTY PHARMA PLC shareholders Q4 2023
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$122,204,89747.65%
Vantage Consulting Group Inc 1,022,194$36,829,65020.91%
Indie Asset Partners, LLC 433,000$15,600,99018.22%
Overbrook Management Corp 578,783$20,853,5515.46%
Silicon Valley Community Foundation 1,032,320$37,194,4905.36%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,047,049$109,785,1754.64%
Geo Capital Gestora de Recursos Ltd 142,748$5,1433.81%
Renaissance Capital LLC 123,913$4,464,5853.31%
Rokos Capital Management LLP 1,106,813$40,077,6982.96%
Lagoda Investment Management, L.P. 101,500$3,657,0452.60%
View complete list of ROYALTY PHARMA PLC shareholders